| Skaneateles Dental Associates, Pllc | |
|
645 W Genesee Street Rd Skaneateles NY 13152-9363 | |
| (315) 685-7162 | |
| (315) 685-2055 |
| Full Name | Skaneateles Dental Associates, Pllc |
|---|---|
| Speciality | Dentist - General Practice |
| Location | 645 W Genesee Street Rd, Skaneateles, New York |
| Authorized Official Name and Position | Lee C Turner (OFFICE MANAGER) |
| Authorized Official Contact | 3156857162 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Skaneateles Dental Associates, Pllc 645 W Genesee Street Rd Skaneateles NY 13152-9363 Ph: (315) 685-7162 | Skaneateles Dental Associates, Pllc 645 W Genesee Street Rd Skaneateles NY 13152-9363 Ph: (315) 685-7162 |
| NPI Number | 1144581562 |
|---|---|
| Provider Enumeration Date | 06/01/2012 |
| Last Update Date | 06/01/2012 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144581562 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | (* (Not Available)) | Primary |
News Archive
Punitive laws and human rights abuses are costing lives, wasting money and stifling the global AIDS response, according to a report by the Global Commission on HIV and the Law, an independent body of global leaders and experts. The Commission report, "HIV and the Law: Risks, Rights and Health," finds evidence that governments in every region of the world have wasted the potential of legal systems in the fight against HIV.
Health care in the last six months of life has become progressively more expensive for patients with heart failure both among Medicare beneficiaries in the United States and older adults in Canada, with a high rate of hospitalizations in the final six months of life in both countries, according to two reports posted online today that will be published in the February 14 print issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
UCB announced today that the U.S. Food and Drug Administration (FDA) approved Neupro (Rotigotine Transdermal System) for the treatment of the signs and symptoms of advanced stage idiopathic Parkinson's disease (PD) and as a treatment for moderate-to-severe primary Restless Legs Syndrome.
Many studies have established that coronavirus disease 2019 (COVID-19) is more infective in men than women, and men are more at risk of severe disease. While some have suggested that behavioral differences could explain increased transmission to men, this does not explain the more morbid prognosis.
Urigen Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development of treatments for urological disorders and pain, announced today that it has filed a request for an FDA meeting to advance the URG101 clinical program and mutually agreed with Oceana Therapeutics, Inc. to terminate their Consulting Agreement effective immediately.
› Verified 1 days ago